Cargando…
Establishing a single-sex controlled human Schistosoma mansoni infection model for Uganda: protocol for safety and dose-finding trial
Control of schistosomiasis depends on a single drug, praziquantel, with variable cure rates, high reinfection rates, and risk of drug resistance. A vaccine could transform schistosomiasis control. Preclinical data show that vaccine development is possible, but conventional vaccine efficacy trials re...
Autores principales: | Abaasa, Andrew, Egesa, Moses, Driciru, Emmanuella, Koopman, Jan Pieter R, Kiyemba, Ronald, Sanya, Richard E, Nassuuna, Jacent, Ssali, Agnes, Kimbugwe, Geofrey, Wajja, Anne, van Dam, Govert J, Corstjens, Paul L A M, Cose, Stephen, Seeley, Janet, Kamuya, Dorcas, Webb, Emily L, Yazdanbakhsh, Maria, Kaleebu, Pontiano, Siddiqui, Afzal A, Kabatereine, Narcis, Tukahebwa, Edridah, Roestenberg, Meta, Elliott, Alison M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10396375/ https://www.ncbi.nlm.nih.gov/pubmed/37538934 http://dx.doi.org/10.1093/immadv/ltad010 |
Ejemplares similares
-
Risk assessment for the implementation of controlled human
Schistosoma mansoni infection trials in Uganda
por: Koopman, Jan Pieter, et al.
Publicado: (2019) -
Ethical and scientific considerations on the establishment of a controlled human infection model for schistosomiasis in Uganda: report of a stakeholders’ meeting held in Entebbe, Uganda.
por: Elliott, Alison M., et al.
Publicado: (2018) -
Ethical and practical considerations arising from community consultation on implementing controlled human infection studies using Schistosoma mansoni in Uganda
por: Egesa, Moses, et al.
Publicado: (2022) -
Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings
por: Driciru, Emmanuella, et al.
Publicado: (2021) -
Does Intensive Treatment Select for Praziquantel Resistance in High-Transmission Settings? Parasitological Trends and Treatment Efficacy Within a Cluster-Randomized Trial
por: Tushabe, John Vianney, et al.
Publicado: (2020)